Leading Players in Thailand Ivermectin Market | Competitive Landscape 2026

Leading Players in Thailand Ivermectin Market

Thailand ivermectin market is a specialized segment of the nation's pharmaceutical landscape, primarily split between human health focusing on tropical medicine and a high-volume veterinary sector. MSD, Pfizer, Boehringer Ingelheim, and Siam Pharmaceutical are some of the key players.

Thailand Ivermectin Market Overview

According to 6Wresearch, the Thailand ivermectin market is projected to maintain steady demand, driven by the country's agricultural backbone and ongoing public health initiatives. In human medicine, ivermectin remains a critical tool for parasitic illnesses including strongyloidiasis and scabies, especially in rural areas. However, the veterinary segment accounts for a considerable portion of the market volume, as ivermectin is a staple antiparasitic for Thailand's massive livestock and aquaculture industries.

The Thai Food and Drug Administration (FDA) is actively implementing stricter regulatory oversight to prevent off-label use and ensure that only registered medical and veterinary products reach customers.

Competitive Landscape

The competitive landscape of the Thailand ivermectin market is dominated by multinational research-driven enterprises in the high-margin innovator and veterinary specialty segments. Domestic firms are increasingly investing in international manufacturing standards (PIC/S GMP) to support Thailand's role as a regional pharmaceutical hub for Southeast Asia.

Below is a list of leading players operating in the Thailand Ivermectin Market:

1. Merck & Co., Inc. (MSD)

The innovator of ivermectin, MSD remains a critical player in Thailand through the Mectizan Donation Program and the supply of specialized antiparasitic medications for both humans and animals.

2. Pfizer Inc.

Pfizer provides a robust range of anti-infective and parasitic therapies used in Thai hospital networks, maintaining a high standard for patient care.

3. Boehringer Ingelheim

A major leader in the Thai veterinary market, supplying high-efficacy ivermectin formulations for livestock and domestic pets.

4. Siam Pharmaceutical Co., Ltd.

A premier domestic manufacturer that produces high-quality generic antiparasitics used extensively in the public health sector.

5. Bayer AG

Bayer contributes significantly to the Thai market through its Animal Health division, offering diverse ivermectin-based solutions for parasitic control in pets and farm animals.

6. Galderma

Supplies the Thai dermatological market with ivermectin-based topical treatments for conditions such as rosacea, catering to private clinics and skincare centers.

7. Zoetis Inc.

As a leading global animal health company, Zoetis provides advanced ivermectin-based parasiticides essential for Thailand's livestock industry.

8. The Government Pharmaceutical Organization (GPO)

The state-run GPO ensures the national supply of essential antiparasitics, focusing on affordability and accessibility for public health programs.

9. Berlin Pharmaceutical Industry

One of Thailand's oldest local pharmaceutical firms, specializing in high-standard anti-infective generics for domestic and regional distribution.

10. Vetoquinol S.A.

A global veterinary giant that supplies a variety of specialized ivermectin products for Thailand's diverse animal health needs.

11. Polipharm Co., Ltd.

Focuses on the manufacture of cost-effective generic antiparasitics, supporting the government's goals for pharmaceutical self-reliance.

12. Virbac

Dedicated to animal health, Virbac supplies the Thai market with advanced ivermectin delivery systems for livestock management.

13. T.O. Chemicals Ltd.

A major local producer of generic oral and topical medications, providing various anti-infective options for the Thai population.

14. Greater Pharma Co., Ltd.

A key domestic player that manufactures and distributes a wide range of pharmaceutical products, including antiparasitic treatments.

Leading Players in Thailand Ivermectin Market: FAQs